An autophagy-inhibitory MOF nanoreactor for tumor-targeted synergistic therapy†
Abstract
An autophagy-inhibitory metal–organic framework (MOF) nanoreactor was developed for tumor-targeted synergistic therapy. The nanoreactor could inhibit autophagy to enhance the glucose oxidase (GOx)-mediated starvation therapy. The H2O2 generated in this process induced the polarization of macrophages to the M1 phenotype, which further enhanced the therapeutic effect.

Please wait while we load your content...